Literature DB >> 552301

Detection of drug-induced disease.

D H Lawson.   

Abstract

Mesh:

Year:  1979        PMID: 552301      PMCID: PMC1429727          DOI: 10.1111/j.1365-2125.1979.tb05914.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt; J Koch-Weser
Journal:  Am Heart J       Date:  1976-08       Impact factor: 4.749

2.  Clinical toxicity of reserpine in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D K Greenblatt; J Koch-Wester
Journal:  Am J Med Sci       Date:  1976 May-Jun       Impact factor: 2.378

Review 3.  Detection of drug-induced disease.

Authors:  D H Lawson
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

4.  Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Am Heart J       Date:  1973-10       Impact factor: 4.749

5.  Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.

Authors:  A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

Review 6.  Unwanted effects of drugs.

Authors:  R Doll
Journal:  Br Med Bull       Date:  1971-01       Impact factor: 4.291

7.  Detection of drug-induced disease.

Authors:  J Koch-Weser
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

Review 8.  Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.

Authors:  D J Greenblatt; J Koch-Weser
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  H J Pfeifer; D J Greenblatt; J Koch-Weser
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.